InnSight Technology, Inc
PITTSBURGH, PA · CIK 0001956287 · Medtech · Private
premium domain name (InnSight.ai)
atom.com →- Grants
- $900K
- 2 awards
- Sector median: 1
- Raised
- $120K
- 1 Form D · Dec 2022
- 46 months since last filing
- Contracts
- $1.3M
- 1 award · Defense
- #281 of 4531 in medtech
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Novel, point-of-service device for use in diagnosing the severity of anterior eye injures with an objective measure of the ocular tear film | $150,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Novel, point-of-service device for use in diagnosing the severity of anterior eye injures with an objective measure of the ocular tear film | $749,973 | |
| Private capital raised | Form D · SEC | $120,000 | |
| Federal contract | Department of Defense · Innsight Technology, Inc. Defense Health Agency Small Business Innovation Research Direct Phase II Novel, Handheld Biosensor For Real Time Detection Of Full-thickness Corneal Injuries In Civilian And Military Personnel | $1,299,975 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 278 | Cellmic, LLC | $1.3M | — |
| 279 | Pharmaseq, Inc | $1.3M | — |
| 280 | LUMENASTRA | $1.3M | — |
| 281 | InnSight Technology, Inc | $1.3M | $120K |
| 282 | MEDSHAPE, INC. | $1.3M | $3.1M |
| 283 | ENUMAGE INC. | $1.3M | — |
| 284 | INTELLIGENT HEARING SYSTEMS | $1.3M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Leanne LabriolaDirector · Executive Officer
Patents
- Detection Of Glycated Albumin In Diabetes-affected Biological Samplesapplication
- Point of Care Device for Detection of Analytes in Tear Film and Other Biological Samplesapplication
- Detection of Glycated Albumin in Diabetes-Affected Biological Samplesapplication
- Point of Care Device for Detection of Analytes in Tear Film and Other Biological Samplesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.